600750.SH
China Resources Jiangzhong Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 22.52
−8.53%Aug 21, 2026, 10:31 UTC
China Resources Jiangzhong announced its first-half 2026 results: net profit attributable to shareholders was 491 million yuan, down 5.92% year-on-year.
Source:Aug 21, 2026, 10:31 UTC
China Resources Jiangzhong proposed a cash dividend of 5 yuan per 10 shares, totaling 318 million yuan.
Source:Aug 3, 2026, 04:21 UTC
China Resources Pharmaceutical's subsidiary China Resources Jiangzhong Pharmaceutical obtained regulatory approval from China's State Administration for Market Regulation for two new special medical foods, expanding its portfolio to four registered products.
Source: